🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Experimental Drug Acquiring Traction Online

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Followers are urged to contact these accounts privately for supplier links, while also receiving promotional offers.

Thriving Trade on Social Networks

Additionally, a flourishing market exists on messaging services, where groups with numerous of participants share “before and after” images, administration instructions and assertions of rapid UK delivery. Sellers market the substance there before redirecting buyers to other platforms for purchases.

Learning About Retatrutide

This medication is an experimental injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.

Medical Experts Express Worries

Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unapproved drug in the United Kingdom is a cause for concern and could result in individuals administering substances of unknown origin.

Several experts said the demand for retatrutide could be linked to the rising price of licensed weight loss products such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the British medical regulations.

Several influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate pharmaceutical, marketing, and customer regulations, potentially leading to fines, prosecution or prison.

Platform Reaction and Content Elimination

According to the social media company, the platform has taken down problematic material and banned associated hashtags and search suggestions. The company stated it was committed to keeping the platform safe and investing in enhancing enforcement strategies.

Digital Marketplace Activities

Research also found communities with up to nine thousand members selling the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up channels with thousands of members, populated with images of slimming results, positive reviews and detailed guides for mixing or administering at home.

After minutes of entering one community, a vendor posted contact information, where the majority of transactions occur. The vendor sent an instruction manual and guaranteed shipping within two days. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one asked about weight, medical conditions or previous experience.

Item Information and Costs

Inside these groups, messages display dark colored packages with postal service stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use pens typically priced at £160 for 20 milligrams. When questioned how long a pen should last, vendors give conflicting answers varying between a several days to “depends on your body”.

Platform Moderation and Security Actions

A representative for Telegram said it actively moderated dangerous material on its service including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting substances they can’t verify. Although the science behind retatrutide is valid, these online products may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are using social media. But counterfeit injections are highly risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.

Her team has previously seen patients harmed by personal administration from unverified suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this point no one can market [it] for personal consumption,” they said, adding that any item “falsely representing itself as a Lilly investigational product not yet authorized … may subject users to potentially serious medical dangers”.